Two established cell lines, H 292 and HEp-2, originating from the human respiratory tract, were found to be significantly more efficient and practical than the currently used HeLa 229 cells for growth of Chlamydia pneumoniae. Six strains of C. pneunoniae recently isolated from patients with respiratory ailments were used as test cultures. The H 292 and HEp-2 cells yielded much higher inclusion counts for all the test strains than did HeLa 229 cells. When they were compared with each other, H 292 cells yielded more inclusions than did HEp-2 cells, and the differences were statistically significant in 10 of 18 test sets. A simple system with these two cell lines appeared to be very efficient for culturing C. pneumoniae. It does not require treatment of tissue cells with DEAE-dextran before infection, and it may eliminate the need for serial subpassages of specimens to increase culture sensitivity. Monolayers of these cells remained intact and viable in the Chlamydia growth medium so that reinfection could take place, resulting in greatly increased inclusion counts for specimens containing few infectious units. This system may make it more practical for laboratories to culture for C. pneumoniae for treatment of infections and outbreak intervention and will facilitate studies on this recently recognized pathogen.
Chlamydia pneumoniae, a new species of the obligate intracellular chlamydiae, has been recognized as a significant pathogen that causes infections of the human respiratory tract and possibly other organs (5, 6, 12, 13, 16) . Diagnosis of infections with C. pneumoniae is problematic, because the syndrome usually presents few distinguishing features and culture of the organism is difficult. Hence, most clinical and epidemiological studies have relied on restrospective serologic tests for specific antibody responses. Limitations of these laboratory diagnostic techniques (5, 7) have hindered investigation of the organism and disease control. Conditions that would promote the growth of C. pneumoniae in tissue cells appear to be different from some of those for C. trachomatis, because cell lines and techniques which enhanced the growth of C. trachomatis were found to be ineffective for C. pneumoniae (7, 9) . The cell line HeLa 229 pretreated with DEAE-dextran has been used most often for culturing C. pneumoniae (7) . Recently, the HL cell line has been found to be more efficient than HeLa 229 cells for culturing the type strain TW 183 (3) and some other isolates (8) . In the search for a more efficient and practical cell culture system, we studied the growth of six recent clinical isolates of C. pneumoniae in selected cell lines derived from the human respiratory tract and found that two established cell lines, H 292 and HEp-2, were significantly more efficient than HeLa 229 cells for culturing all of the test strains. Our findings and a relatively simple and more efficient culture system for C. pneumoniae are presented in this report.
MATI,RIALS AND METHODS
Bacteria. C. pneumoniae CWL 029 (ATCC VR-1310) (2) and CM-1 were isolated from patients with pneumonia in laboratories at the Centers for Disease Control, Atlanta, Ga. Strains FML 7 , FML 10 , FML 12, FML 16, and FML 19 H 292 (ATCC H-292), lung carcinoma; RU 1, fetal lung fibroblast; HEp-2, larnyx carcinoma; HR 6, embryonic lung; and WI 38, embryonic lung.
Comparison of culture efficiencies of cell lines. Monolayers of tissue cells were cultured at 36°C in 5% CO2 in the following cell growth medium: Eagle's minimal essential medium supplemented with fetal calf serum (10%), L-glutamine (2 mM), MEM nonessential amino acids (10 ml/liter; 1OOx; GIBCO, Grand Island, N.Y.), HEPES (N-2-hydroxyethylpiperazine-N'-2-ethanesulfonic acid) buffer (10 mM), gentamicin (10 mg/liter), and vancomycin (25 mg/liter).
The strains of C. pneumoniae to be used for testing the cell lines were grown in HeLa 229 cell monolayers in six-well culture plates (Costar, Cambridge, Mass. (4) , with modifications of the fusion techniques as described by Lane (10 10' infectious units by the intraperitoneal route, which was followed by one dose of 0.2 ml by the intravenous route. Spleens were collected for fusion 3 days after the last injection.
The specificities of the monoclonal antibodies were determined by an indirect immunofluorescence test by using strains of C. pneumnoniae, C. psittaci, and C. trachomatis as antigens and fluorescein isothiocyanate conjugates of goat anti-mouse IgG and IgM (Sigma) as secondary antibodies. A pool of ascitic fluids produced in young adult BALB/c mice with the selected monoclone was used for staining C. pneumoniae.
Statistical methods. Statistical analyses for comparing the efficiencies of the cell lines for culturing C. pneumoniae with regard to strains and inoculum concentrations, including the techniques of analysis of variance (14) and Scheffe's simultaneous confidence intervals (11), were performed for each of the 18 test sets. It was observed that the standard deviations of inclusion counts were proportional to the means. Inclusion counts on a logarithmic scale were used in the analyses. Analysis of variance for randomized complete block design was adopted to test the null hypothesis that the inclusion counts of three cell lines were the same. Each inoculum was considered as a block in this design. The test statistic for testing the null hypothesis was calculated. The test statistic would have a F(u,v) distribution with the degrees of freedom u = 2 and v = 10 if the null hypothesis was true. The P value associated with the test statistic was then determined. When the hypothesis of equal means was rejected, Scheffe's 95% simultaneous confidence intervals for mean difference between cell lines were constructed, and the significances of differences among the comparisons were determined.
RESULTS
Monoclonal antibodies. Six monoclones excreting IgG antibodies to C. pneulmoniae CLW 029 were identified. Clone 2D11 was genus specific, reacting with C. trachomatis, C. psittaci, as well as C. pneumoniae; and the other five clones-3F12, 3G9.1, 5E1.1, 7D10, and 8A6-were species specific, with no cross-reaction with C. trachomatis or C.
psittaci. Clone 7D10 was selected for production of antibody in BALB/c mice for identifying and counting C. pneumoniae inclusions in tissue cultures, because this clone was well tolerated by the host and produced high titers of antibody. The fusion procedure as modified by Lane (10) appeared to be very efficient in producing monoclones to antigens of C.
pneumoniae.
Screening of cell lines for culture efficiencies. The five cell lines were screened for their efficiencies in culturing the C. pneumoniae isolates relative to those of HeLa 229 cells. Monolayers of the H 292 and HEp-2 cells consistently yielded higher inclusion counts than HeLa 229 cells did, whereas inclusion counts in RU 1, HR 6, and WI 38 cells were less. The results in Table 1 Representative results are presented in Table 2 . Pretreatment with DEAE-dextran at 20 ,ug/ml slightly enhanced the A culture system for C. pneumoniae. A system for culturing C. pneumoniae emerged from the findings of this study and is outlined in Fig. 1 EFFICIENT CULTURE OF C. PNEUMONME test strains were invariably higher in H 292 cells than they were in HEp-2 cells. The H 292 cell line was the most efficient for growing C. pneumoniae cultures.
Second Recently, the HL cell line has been reported to be more efficient than the HeLa 229 cell line for growing C. pneumoniae (3, 8) . Because of the differences in experimental design and test strains, the results obtained with the HL cell line cannot be directly compared with those of the present study. However, as more cell lines are identified as being more efficient in various aspects than HeLa 229 cells for culturing C. pneumoniae and the culture procedure becomes technically less demanding, advances in our understanding of this pathogen and control of the diseases it causes will be greatly facilitated. (2) . We have also been working on using PCR for detection of cytomegalovirus, herpes simplex virus, and VZV in the aqueous humor of human immunodeficiency virus type 1-positive patients (1) . Therefore, we examined the primer sequences mentioned in the above publication and compared their primer and PCR protocol with our VZV primer and protocol. We were pleased to see that the sensitivity and specificity of our primer were the same as those described by Kido et al., with the exception of IE1 and IE2 (gene 62). However, it seems that this primer does not work very well with the PCR protocol of Kido et al. We present our modified protocol, which in our experience had a much better sensitivity. We tested each modification of this new PCR protocol with highly purified VZV DNA, with supernatant of tissue culture of VZV-infected fibroblasts, and with VZV-positive aqueous humor of a patient with VZV retinitis. The DNA samples were first heated at 95°C for 10 min. DNA was amplified in a total volume of 50 ,ul of reaction mixture consisting of 50 mM KCI, 10 mM Tris hydrochloride (pH 8.3), 1.5 mM MgCl2, 0.01% gelatin, 200 ,uM (each) deoxynucleoside triphosphates (dNTPs), and 1.5 U of Taq polymerase (Perkin-Elmer Cetus). Denaturation was performed at 94°C for 30 s. Annealing was performed at 58°C for 30 s, and extension was performed at 72°C for 90 s. The amplification was carried out in 35 cycles in a DNA thermal cycler (Perkin-Elmer Cetus). It is important to note that with this protocol the user saves expensive dNTPs and Taq polymerase because it can be done with half the volume of reaction mixture. Moreover, PCR amplification can be done much faster with our protocol, and the detection of the amplified product can be started on the same day. We consider this to be important as a rapid viral diagnostic tool.
